$RBA · RB Global, Inc. Congress Trades

Rep. Lisa McClain (MI-09) conducted extensive trading activity across her Charles Schwab brokerage and 401(k) accounts from March 2024 through August 2025, trading dozens of stocks including major tech companies (AAPL, GOOGL, GOOG, AMZN, ADBE, AMD), healthcare (ABT, ABBV, AMGN, AZN), and industrials (ASML, ACN, AMAT). Most individual transactions ranged from $1,001-$15,000, with one AMD sale reaching $15,001-$50,000. The filing shows frequent buy-and-sell activity in the same securities within weeks, suggesting active portfolio management.

Rep. Gilbert Cisneros (CA-31) executed a substantial portfolio rebalancing in March 2025, with purchases totaling over $1 million across diverse sectors including a major $1-5 million investment in Audent Hospitality Real Estate Fund I L.P., plus significant buys in healthcare (UNH, JNJ, MRK), technology (ASML, MSFT), and industrials (BA, FERG, PTC), while simultaneously selling positions in healthcare, technology, and industrials stocks ranging from $1,001 to $50,000 each.

Rep. Josh Gottheimer made 12 transactions in a Morgan Stanley Select UMA Account during December 2022, involving purchases and partial sales of pharmaceutical and healthcare stocks including Amgen, ADP, Blackstone, Eli Lilly, Fidelity National Information Services, HaloZyme, Insmed, Pharmaceutical GRP, Ritchie Bros., Shoals Technologies, Supernus Pharmaceuticals, and Syneos Health, with all transactions valued between $1,001-$15,000.

Rep. Josh Gottheimer (NJ-05) executed a broad portfolio rebalancing in July 2022, purchasing 18 stocks including major tech holdings (GOOG, AAPL, MSFT, ORCL) and financials (COF, EFX, FIS, UNH), while simultaneously selling partial positions in GOOG, DE, MEDP, NOVT, and RBA. Most transactions ranged from $1,001-$15,000, with Starbucks (SBUX) at the higher range of $15,001-$50,000. All trades occurred through Morgan Stanley Active Asset Account #1.